This study advances our understanding of the role of lncRNAs such as SPRY4-IT1 as regulators of NSCLC pathogenesis, and facilitates the development of lncRNA-directed diagnostics and therapeutics. The gene discussed is SPRY4; the disease is non-small cell lung carcinoma.